Medical/Pharmaceuticals APAC News & Press Release Distribution

Resource for journalists around the world on COVID-19 vaccines

covidvaccinehub.org (https://covidvaccinehub.org/ ) If you're a fact checker or a journalist, we're here to help you find the information and experts you need for your story. SYDNEY, Nov. 22, 2021 /PRNewswire/ -- The COVID-19 Vaccine Media Hub ( https://covidvaccin...

2021-11-22 16:49 2078

Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed After EGFR-TKI Therapy at ESMO Virtual Plenary 2021

SAN FRANCISCO and SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-11-22 08:16 4384

Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index

SAN FRANCISCO and SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-11-22 08:00 5018

CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China

SUZHOU, China, Nov. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Jiangsu Hengrui Pharmaceuticals ("Hengru...

2021-11-21 17:09 4455

US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics

LONDON, Nov. 20, 2021 /PRNewswire/ -- Datar Cancer Genetics, a leading cancer research company focussed on early detection of cancers today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its blood test to detect early-stage Breast Cancer...

2021-11-20 08:00 6959

US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics

Vela Diagnostics expands automation options for SARS-CoV-2 RT-PCR Test

FAIRFIELD, N.J., Nov. 20, 2021 /PRNewswire/ -- Vela Diagnostics announced today that the ViroKey® SARS-CoV-2 RT-PCR Test v2.0 that received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), can now be used with the KingFisher FLEX system and Hamilton Microlab STA...

2021-11-20 01:15 4880

SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing

Based on Highly-Purified Isomers of Tannic Acid and Acting as a Dual Protease and TMPRSS2 Inhibitor, Pentarlandir Has Shown Significant Anti-Viral Properties with Minimal Observed Side Effects NEW TAIPEI CITY, Taiwan and TORRANCE, Calif., Nov. 20, 2021 /PRNewswire/ -- SyneuRx™ International, (Ta...

2021-11-20 01:00 4022

UAE to receive award from Parliamentary Assembly of the Mediterranean for Waterfalls Initiative

ROME, Nov. 19, 2021 /PRNewswire/ -- On Thursday November 18, in the Sala Protomoteca of the Campidoglio inRome, the United Arab Emirates, represented by Saif bin Zayed, Deputy Prime Minister and Minister of the Interior received an award from the Parliamentary Assembly of the Mediterranean (PAM) ...

2021-11-19 21:33 3995

Brii Biosciences Joins Hang Seng Composite Index

DURHAM, N.C. and BEIJING, Nov. 19, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), today announced that Brii Biosciences has been included as a constituent stock of the Hang Seng Composite Index. Dr. Ankang L...

2021-11-19 19:06 4793

YHLO Revealed Its New Development of CLIA Technology at MEDICA 2021

DUSSELDORF, Germany, Nov. 19, 2021 /PRNewswire/ -- Shenzhen YHLO Biotech Co., Ltd (688575.SSE), an innovative and steadfastly growing company of immunoassay solutions, presented its compact and automated chemiluminescence immunoassay (CLIA) analyzer iFlash 1200 at Medica 2021, a world-renowned tr...

2021-11-19 14:43 2756

Treating Patients Beyond Borders - Antengene Successfully Hosted Its First R&D Day

- Highlighted R&D Strategy and Broad Pipeline of 15 Programs including 10 with Worldwide Rights - ATG-010's First Approval in Asia transforms Antengene into a Commercial Entity, 10 Studies in ATG-010 being Conducted in Mainland China - Exciting ATG-008 (mTORC1/2 inhibitor) Signal, ATG-017 (ER...

2021-11-19 13:00 5242

Treating Patients Beyond Borders - Antengene Successfully Hosted Its First R&D Day

EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider

- EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction - Icon Group is Australia's largest vertically integrated cancer care...

2021-11-19 10:21 4305

Fiji based Omnicare Successfully Adopts the Digital Health Platform Jointly Provided by EnoviQ and InsureMO

SINGAPORE, Nov. 19, 2021 /PRNewswire/ -- EnoviQ, a health Insurance platform provider and eBaoTech, a digital Insurance solution provider are pleased to share their joint success in launching a digital health platform for Omnicare Pte. Ltd. (Omnicare) inFiji, to provide medical services to its na...

2021-11-19 10:00 3894

Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment

BRISBANE, Australia, Nov. 19, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT. The investment demonstrates confidence in the stre...

2021-11-19 09:19 3025

Antengene Announces IND Approval in China for a Phase I/II Study of Selinexor (ATG-010) in Patients with Non-Hodgkin Lymphoma

SHANGHAI and Hong Kong, Nov. 19, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-11-19 08:30 4311

Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance

SEOUL, South Korea, Nov. 18, 2021 /PRNewswire/ -- Lunit, a leading medical AI provider, today announced that the US Food and Drug Administration (FDA) 510(k) has cleared its AI solution for breast cancer detection, 'Lunit INSIGHT MMG'. Along with its chest x-ray triaging solution 'Lunit INSIGHT C...

2021-11-18 22:00 2790

Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance

Betagenon co-founder publishes study demonstrating that pan-AMPK activator O304 acts as an exercise mimetic in aged mice

STOCKHOLM, Nov. 18, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Prof.Helena Edlund of a new study demonstrating that in aged mice the pan-AMPK activator O304 improves cardiac function a...

2021-11-18 21:32 1947

The Sigourney Award-2021 Honors Three Recipients With Distinguished International Prize for Advancing Psychoanalytic Thought

SEATTLE, Nov. 18, 2021 /PRNewswire/ -- The Sigourney Award annually rewards achievements that advance psychoanalytic thought and practice with international recognition and a substantial cash prize. This year, a panel of distinguished judges evaluated applications from five continents for The Si...

2021-11-18 21:14 2323

The Sigourney Award-2021 Honors Three Recipients With Distinguished International Prize for Advancing Psychoanalytic Thought

Treadwell Therapeutics Announces The Closing of a $91 Million Series B Financing

NEW YORK and HONG KONG, Nov. 18, 2021 /PRNewswire/ -- Treadwell Therapeutics ("Treadwell"), a clinical-stage biotechnology company developing novel, cross-modality medicines for unmet needs in cancer, today announced the closing of an oversubscribed Series B financing, which raised more than$91...

2021-11-18 20:00 3653

ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth

Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer LONDON, Nov. 18, 2021 /PRNewswire/ -- ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a specialty pharmaceutical company with a strategic focus on complex medicines in ...

2021-11-18 15:45 5664